Crinetics Pharmaceuticals Ownership 2024 | Who Owns Crinetics Pharmaceuticals Now?
Institutional Ownership
14.79%
Insider Ownership
2.08%
Retail Ownership
83.12%
Institutional Holders
95.00
Crinetics Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 8.62% | 0.01% | 6,230,371 | 794,267 | 14.61% | 279,058,317 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 8.46% | 2.64% | 6,112,173 | 885,876 | 16.95% | 273,764,229 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.39% | 0.04% | 4,620,413 | 1,648,831 | 55.49% | 206,948,298 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.25% | 0.00% | 4,514,478 | 939,402 | 26.28% | 202,203,469 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.10% | 0.02% | 4,406,456 | 583,238 | 15.26% | 197,366,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 5.75% | 5.69% | 4,155,375 | - | - | 186,119,246 | Jun 30, 2024 |
| FMR LLC | 5.67% | 0.01% | 4,096,795 | -366,881 | -8.22% | 183,495,468 | Jun 30, 2024 |
| STATE STREET CORP | 3.89% | 0.01% | 2,812,923 | -442,330 | -13.59% | 125,990,821,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.85% | 0.33% | 2,780,856 | -2,168,630 | -43.82% | 124,554,540 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 3.85% | 0.08% | 2,780,144 | -37,710 | -1.34% | 124,522,651 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.48% | 4.31% | 2,513,302 | -611,447 | -19.57% | 112,570,797 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.40% | 0.06% | 2,455,661 | 477,489 | 24.14% | 109,969,620 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.32% | 0.01% | 1,678,387 | 276,984 | 19.76% | 75,189,113 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.04% | 1.57% | 1,476,203 | - | - | 66,119,132 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.87% | 3.49% | 1,350,000 | 200,000 | 17.39% | 60,466,500 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.86% | 0.04% | 1,347,210 | -1,307,519 | -49.25% | 60,342,000 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.77% | 1.14% | 1,280,800 | -104,200 | -7.52% | 57,367,032 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.66% | 4.71% | 1,200,508 | -489,669 | -28.97% | 53,770,753 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.47% | 1.22% | 1,066,064 | -324,413 | -23.33% | 47,749,007 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.38% | 2.60% | 1,000,000 | -98,600 | -8.98% | 44,790,000 | Jun 30, 2024 |
Crinetics Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 8.62% of the company's total share outstanding, currently valued at $279.06M. The top 10 institutional shareholders own together 58.81% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SATURN V CAPITAL MANAGEMENT LLC | 0.66% | 8.12% | 479,681 | -180,462 | -27.34% | 21,484,912 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 0.20% | 7.68% | 141,000 | - | - | 6,315,390 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.76% | 7.25% | 551,095 | -68,694 | -11.08% | 24,683,545 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 5.75% | 5.69% | 4,155,375 | - | - | 186,119,246 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.19% | 5.10% | 135,141 | 56,738 | 72.37% | 6,052,965 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.66% | 4.71% | 1,200,508 | -489,669 | -28.97% | 53,770,753 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.81% | 4.59% | 588,818 | -54,933 | -8.53% | 26,373,158 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.48% | 4.31% | 2,513,302 | -611,447 | -19.57% | 112,570,797 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.77% | 3.88% | 557,184 | 76,596 | 15.94% | 24,956,271 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.87% | 3.49% | 1,350,000 | 200,000 | 17.39% | 60,466,500 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.33% | 3.37% | 240,000 | 40,000 | 20.00% | 10,749,600 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.51% | 2.69% | 369,302 | 369,302 | 100.00% | 16,541,037 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.71% | 2.66% | 515,000 | 45,000 | 9.57% | 23,066,850 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 8.46% | 2.64% | 6,112,173 | 885,876 | 16.95% | 273,764,229 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.38% | 2.60% | 1,000,000 | -98,600 | -8.98% | 44,790,000 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.22% | 2.17% | 157,958 | - | - | 7,074,939 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.55% | 1.70% | 400,000 | 75,000 | 23.08% | 17,916,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.04% | 1.57% | 1,476,203 | - | - | 66,119,132 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.21% | 1.31% | 150,183 | 93,781 | 166.27% | 6,726,697 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.47% | 1.22% | 1,066,064 | -324,413 | -23.33% | 47,749,007 | Jun 30, 2024 |
The largest Crinetics Pharmaceuticals shareholder by % of total assets is SATURN V CAPITAL MANAGEMENT LLC. The company owns 479.68K shares of Crinetics Pharmaceuticals (CRNX), representing 8.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 6.39% | 0.04% | 4,620,413 | 1,648,831 | 55.49% | 206,948,298 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.25% | 0.00% | 4,514,478 | 939,402 | 26.28% | 202,203,469 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 8.46% | 2.64% | 6,112,173 | 885,876 | 16.95% | 273,764,229 | Jun 30, 2024 |
| BLACKROCK INC. | 8.62% | 0.01% | 6,230,371 | 794,267 | 14.61% | 279,058,317 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.10% | 0.02% | 4,406,456 | 583,238 | 15.26% | 197,366,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.90% | 0.19% | 653,557 | 518,264 | 383.07% | 29,272,816 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.69% | 0.10% | 497,000 | 492,000 | 9840.00% | 22,260,630 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.40% | 0.06% | 2,455,661 | 477,489 | 24.14% | 109,969,620 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.19% | 0.01% | 861,422 | 448,213 | 108.47% | 38,583,092 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 0.57% | 0.38% | 410,342 | 410,342 | 100.00% | 18,379,218 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.51% | 2.69% | 369,302 | 369,302 | 100.00% | 16,541,037 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.54% | 0.03% | 390,941 | 296,074 | 312.09% | 17,510,247 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.42% | 0.02% | 300,868 | 291,501 | 3112.00% | 13,475,878 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.32% | 0.01% | 1,678,387 | 276,984 | 19.76% | 75,189,113 | Jun 30, 2024 |
| MORGAN STANLEY | 1.16% | 0.00% | 838,625 | 226,425 | 36.99% | 37,562,093 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.87% | 3.49% | 1,350,000 | 200,000 | 17.39% | 60,466,500 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.32% | 0.01% | 229,909 | 180,651 | 366.74% | 10,297,624 | Jun 30, 2024 |
| MAPLELANE CAPITAL, LLC | 0.22% | 0.25% | 160,000 | 160,000 | 100.00% | 7,166,400 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.21% | 0.07% | 150,000 | 150,000 | 100.00% | 6,718,500 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.20% | 0.01% | 141,204 | 141,204 | 100.00% | 6,324,528 | Jun 30, 2024 |
As of Jun 30 2024, Crinetics Pharmaceuticals's largest institutional buyer is WELLINGTON MANAGEMENT GROUP LLP. The company purchased 1.65M stocks of CRNX, valued at $206.95M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 3.85% | 0.33% | 2,780,856 | -2,168,630 | -43.82% | 124,554,540 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.86% | 0.04% | 1,347,210 | -1,307,519 | -49.25% | 60,342,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.48% | 4.31% | 2,513,302 | -611,447 | -19.57% | 112,570,797 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.66% | 4.71% | 1,200,508 | -489,669 | -28.97% | 53,770,753 | Jun 30, 2024 |
| STATE STREET CORP | 3.89% | 0.01% | 2,812,923 | -442,330 | -13.59% | 125,990,821,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.28% | 0.02% | 201,048 | -431,085 | -68.20% | 9,004,940 | Jun 30, 2024 |
| FMR LLC | 5.67% | 0.01% | 4,096,795 | -366,881 | -8.22% | 183,495,468 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.02% | 0.56% | 735,088 | -324,545 | -30.63% | 32,924,592 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.47% | 1.22% | 1,066,064 | -324,413 | -23.33% | 47,749,007 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -300,400 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.49% | 0.19% | 350,766 | -279,416 | -44.34% | 15,710,809 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.06% | 0.00% | 43,184 | -221,827 | -83.70% | 1,934,211 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.90% | 0.00% | 649,190 | -214,917 | -24.87% | 29,077,220 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -210,000 | -100.00% | - | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.66% | 8.12% | 479,681 | -180,462 | -27.34% | 21,484,912 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -175,000 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -153,395 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -127,835 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.28% | 0.14% | 199,000 | -120,000 | -37.62% | 8,913,210 | Jun 30, 2024 |
As of Jun 30 2024, Crinetics Pharmaceuticals's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -2.17M shares of CRNX, valued at $124.55M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HOOD RIVER CAPITAL MANAGEMENT LLC | 0.57% | 0.38% | 410,342 | 410,342 | 100.00% | 18,379,218 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.51% | 2.69% | 369,302 | 369,302 | 100.00% | 16,541,037 | Jun 30, 2024 |
| MAPLELANE CAPITAL, LLC | 0.22% | 0.25% | 160,000 | 160,000 | 100.00% | 7,166,400 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.21% | 0.07% | 150,000 | 150,000 | 100.00% | 6,718,500 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.20% | 0.01% | 141,204 | 141,204 | 100.00% | 6,324,528 | Jun 30, 2024 |
| MAN GROUP PLC | 0.17% | 0.01% | 125,714 | 125,714 | 100.00% | 5,630,730 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.16% | 0.01% | 114,637 | 114,637 | 100.00% | 5,134,591 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.14% | 0.06% | 103,927 | 103,927 | 100.00% | 4,654,890 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.10% | 0.63% | 74,850 | 74,850 | 100.00% | 3,352,532 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.07% | 0.25% | 53,012 | 53,012 | 100.00% | 2,374,407 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.01% | 41,863 | 41,863 | 100.00% | 1,875,044 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 38,390 | 38,390 | 100.00% | 1,713,914 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.04% | 0.03% | 30,631 | 30,631 | 100.00% | 1,371,962 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.03% | 25,282 | 25,282 | 100.00% | 1,132,381 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.03% | 0.00% | 24,798 | 24,798 | 100.00% | 1,110,702 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.03% | 0.00% | 20,128 | 20,128 | 100.00% | 901,533 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 0.02% | 0.01% | 12,836 | 12,836 | 100.00% | 574,924 | Jun 30, 2024 |
| LEWIS ASSET MANAGEMENT, LLC | 0.02% | 0.42% | 12,395 | 12,395 | 100.00% | 555,172 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.09% | 11,317 | 11,317 | 100.00% | 506,888 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 9,062 | 9,062 | 100.00% | 405,887 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.01% | 0.07% | 8,561 | 8,561 | 100.00% | 383,447 | Jun 30, 2024 |
| TAIKANG ASSET MANAGEMENT (HONG KONG) CO LTD | 0.01% | 0.06% | 8,500 | 8,500 | 100.00% | 380,715 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.01% | 0.15% | 8,426 | 8,426 | 100.00% | 377,000 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.01% | 0.00% | 8,000 | 8,000 | 100.00% | 358,320 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.01% | 0.11% | 5,800 | 5,800 | 100.00% | 259,782 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.01% | 0.00% | 5,497 | 5,497 | 100.00% | 246,211 | Jun 30, 2024 |
| XPONANCE, INC. | 0.01% | 0.00% | 4,930 | 4,930 | 100.00% | 220,815 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.02% | 4,919 | 4,919 | 100.00% | 220,000 | Jun 30, 2024 |
| HARBOUR CAPITAL ADVISORS, LLC | 0.01% | 0.05% | 4,550 | 4,550 | 100.00% | 209,619 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.01% | 0.00% | 4,470 | 4,470 | 100.00% | 200,211 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.19% | 2,845 | 2,845 | 100.00% | 127,428 | Jun 30, 2024 |
| ADVISORS ASSET MANAGEMENT, INC. | 0.00% | 0.00% | 1,798 | 1,798 | 100.00% | 80,532 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | 0.00% | 934 | 934 | 100.00% | 42,376 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.00% | 0.01% | 934 | 934 | 100.00% | 41,834 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | 0.00% | 259 | 259 | 100.00% | 11,601 | Jun 30, 2024 |
| FARMERS & MERCHANTS INVESTMENTS INC | 0.00% | 0.00% | 200 | 200 | 100.00% | 8,958 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.00% | - | 192 | 192 | 100.00% | 9,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 182 | 182 | 100.00% | 8,152 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 132 | 132 | 100.00% | 5,738 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 80 | 80 | 100.00% | 3,583 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 36 | 36 | 100.00% | 1,612 | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | - | - | 34 | 34 | 100.00% | 1,523,000 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | 30 | 30 | 100.00% | 1,344 | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | 0.00% | 25 | 25 | 100.00% | 1,000 | Jun 30, 2024 |
| BELL INVESTMENT ADVISORS, INC | - | 0.00% | 15 | 15 | 100.00% | 672 | Jun 30, 2024 |
Crinetics Pharmaceuticals's largest new institutional shareholder by number of shares is HOOD RIVER CAPITAL MANAGEMENT LLC, purchased 410.34K shares, valued at $18.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -300,400 | -100.00% | - | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -210,000 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -175,000 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -153,395 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -127,835 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -88,005 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -87,700 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -43,900 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -32,509 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -27,200 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -11,100 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -10,700 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -7,841 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -7,100 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -6,500 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -4,887 | -100.00% | - | Jun 30, 2024 |
| OPPENHEIMER ASSET MANAGEMENT INC. | - | - | - | -4,276 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,573 | -100.00% | - | Jun 30, 2024 |
| AMUNDI | - | - | - | -3,352 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -2,700 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -245 | -100.00% | - | Jun 30, 2024 |
Crinetics Pharmaceuticals's largest sold out institutional shareholder by shares sold is VIVO CAPITAL, LLC, sold -0.35M shares, valued at -, as of undefined.
Crinetics Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.88% | 39,170 | 28,783 | 277.11% | Feb 29, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.55% | 135,172 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.53% | 487,641 | 487,641 | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.32% | 674,789 | - | - | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.30% | 1,499,632 | 170,302 | 12.81% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.24% | 880,332 | 97,300 | 12.43% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.21% | 101,196 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.14% | 609,531 | 17,597 | 2.97% | Mar 28, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.12% | 372,398 | 150,787 | 68.04% | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.09% | 53,985 | 12,351 | 29.67% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 43,649 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.07% | 666,459 | 18,312 | 2.83% | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.07% | 576,300 | 78,469 | 15.76% | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 439,200 | -500 | -0.11% | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.05% | 113,300 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.04% | 413,251 | 49,300 | 13.55% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 63,679 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,413,650 | 180,600 | 14.65% | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 9,590 | 2,880 | 42.92% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 115,036 | -2,623 | -2.23% | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 86,551 | 25,273 | 41.24% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 201,900 | 45,400 | 29.01% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.02% | 98,988 | 27,405 | 38.28% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,566,200 | 378,100 | 31.82% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,844 | -67 | -0.68% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 132,300 | 56,514 | 74.57% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 130,922 | 87,600 | 202.21% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.01% | 203 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.01% | 463,578 | -29,416 | -5.97% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,843,853 | -827,987 | -22.55% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 180,422 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,406 | - | - | Mar 31, 2024 |
| AMG Funds IV | 0.01% | 16,955 | -250 | -1.45% | Jan 31, 2024 |
| UBS FUNDS | 0.00% | 20,950 | 20,950 | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 175,787 | 258 | 0.15% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 49,691 | 11,060 | 28.63% | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 163,517 | 67,348 | 70.03% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 96,390 | 25,560 | 36.09% | Mar 31, 2024 |
| FORUM FUNDS | 0.00% | 6,180 | -3,550 | -36.49% | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 25,155 | -3,311 | -11.63% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 552,271 | 23,115 | 4.37% | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 31,232 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,759 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 33,189 | -1,540 | -4.43% | Feb 29, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 115,000 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,459 | 4,459 | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 2,353 | -2,496 | -51.47% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 234,549 | 79,321 | 51.10% | Jan 31, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 45,843 | -505 | -1.09% | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 7,553 | - | - | Mar 31, 2020 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 38,454 | -3,071 | -7.40% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 122,430 | -14,943 | -10.88% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 100,905 | 277 | 0.28% | Feb 29, 2024 |
| ProFunds | 0.00% | 11,521 | -2,721 | -19.11% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 21,488 | 2,610 | 13.83% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 17,472 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 61,583 | -83,704 | -57.61% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 179,717 | 27 | 0.02% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,673 | 2,130 | 32.55% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 21,578 | -4,348 | -16.77% | Mar 31, 2024 |
| Global X Funds | 0.00% | 29,232 | - | - | Jan 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 4,370 | 4,370 | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 18,879 | 16,679 | 758.14% | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,139 | -55 | -1.72% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,203 | -593 | -7.61% | Mar 31, 2024 |
| Ultimus Managers Trust | 0.00% | 6,656 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 919 | 80 | 9.54% | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,310 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 303,214 | 12,705 | 4.37% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 58,631 | 37,102 | 172.33% | Feb 29, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 36,144 | 36,144 | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 512,535 | 73,726 | 16.80% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 71,183 | -9,249 | -11.50% | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 223 | - | - | Apr 30, 2021 |
| Meeder Funds | 0.00% | 1,988 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,679 | -448 | -21.06% | Mar 28, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 6,904 | 2,981 | 75.99% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 12,127 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 23,300 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 146,765 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 47,533 | -2,156 | -4.34% | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 899 | - | - | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 1,521 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 76,196 | -73,331 | -49.04% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 338,383 | -122,390 | -26.56% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 25,027 | -5,360 | -17.64% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 85,005 | 83,849 | 7253.37% | Feb 29, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 56,228 | 56,228 | - | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 2,977 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,059,633 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 12,563 | 12,563 | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 268,692 | 66,730 | 33.04% | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 67,100 | 68,829 | -3980.86% | Feb 29, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 13,889 | 4,505 | 48.01% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 223,421 | -1,851 | -0.82% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 827,692 | 109,762 | 15.29% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,926,780 | -66,317 | -2.22% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 4,176 | 3,675 | 733.53% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 866 | - | - | Mar 31, 2024 |
| Dunham Funds | 0.00% | 11,121 | 3,758 | 51.04% | Jan 31, 2024 |
Crinetics Pharmaceuticals's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 39.17K shares, compromising 0.88% of its total assets.
Crinetics Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 95 | -56.82% |
| 31 Mar, 24 | 220 | 11.68% |
| 31 Dec, 23 | 197 | - |
| 30 Sep, 23 | 197 | 40.71% |
| 30 Jun, 23 | 140 | 9.38% |
| 31 Mar, 23 | 128 | 4.07% |
| 31 Dec, 22 | 123 | 4.24% |
| 30 Sep, 22 | 118 | 5.36% |
| 30 Jun, 22 | 112 | -3.45% |
| 31 Mar, 22 | 116 | -1.69% |
| 31 Dec, 21 | 118 | 28.26% |
| 30 Sep, 21 | 92 | 12.20% |
| 30 Jun, 21 | 82 | 5.13% |
| 31 Mar, 21 | 78 | -8.24% |
| 31 Dec, 20 | 85 | 21.43% |
| 30 Sep, 20 | 70 | -11.39% |
| 30 Jun, 20 | 79 | 41.07% |
| 31 Mar, 20 | 56 | -3.45% |
| 31 Dec, 19 | 58 | -4.92% |
| 30 Sep, 19 | 61 | -3.17% |
| 30 Jun, 19 | 63 | 1.61% |
| 31 Mar, 19 | 62 | 24.00% |
| 31 Dec, 18 | 50 | 2.04% |
| 30 Sep, 18 | 49 | - |
As of 30 Jun 24, 95 institutions are holding Crinetics Pharmaceuticals's shares, representing a decrease of -56.82% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 10,694,544 | -86.70% |
| 31 Mar, 24 | 80,408,468 | 13.80% |
| 31 Dec, 23 | 70,656,199 | 3.13% |
| 30 Sep, 23 | 68,511,935 | 27.20% |
| 30 Jun, 23 | 53,863,454 | -2.11% |
| 31 Mar, 23 | 55,022,766 | 0.25% |
| 31 Dec, 22 | 54,887,252 | 6.77% |
| 30 Sep, 22 | 51,405,886 | 1.47% |
| 30 Jun, 22 | 50,661,253 | 11.21% |
| 31 Mar, 22 | 45,553,050 | 2.89% |
| 31 Dec, 21 | 44,275,109 | 31.64% |
| 30 Sep, 21 | 33,632,719 | 2.33% |
| 30 Jun, 21 | 32,867,947 | 6.96% |
| 31 Mar, 21 | 30,730,606 | 1.00% |
| 31 Dec, 20 | 30,426,262 | 0.30% |
| 30 Sep, 20 | 30,335,349 | -3.55% |
| 30 Jun, 20 | 31,451,446 | 52.09% |
| 31 Mar, 20 | 20,679,658 | 17.99% |
| 31 Dec, 19 | 17,526,233 | 15.04% |
| 30 Sep, 19 | 15,234,861 | -19.53% |
| 30 Jun, 19 | 18,931,383 | 6.73% |
| 31 Mar, 19 | 17,737,450 | 5.66% |
| 31 Dec, 18 | 16,786,976 | 3.85% |
| 30 Sep, 18 | 16,164,910 | - |
Crinetics Pharmaceuticals (CRNX) has 10.69M shares outstanding as of 30 Jun 24, down -86.70% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 14.79% | 0.12% |
| 31 Mar, 24 | 111.23% | 0.75% |
| 31 Dec, 23 | 121.67% | 0.84% |
| 30 Sep, 23 | 120.60% | 1.22% |
| 30 Jun, 23 | 99.24% | 0.95% |
| 31 Mar, 23 | 102.07% | 0.92% |
| 31 Dec, 22 | 105.59% | 1.16% |
| 30 Sep, 22 | 95.61% | 1.03% |
| 30 Jun, 22 | 96.46% | 1.05% |
| 31 Mar, 22 | 96.03% | 1.00% |
| 31 Dec, 21 | 97.89% | 1.27% |
| 30 Sep, 21 | 87.79% | 1.12% |
| 30 Jun, 21 | 88.69% | 1.02% |
| 31 Mar, 21 | 93.09% | 0.93% |
| 31 Dec, 20 | 99.93% | 1.17% |
| 30 Sep, 20 | 92.23% | 0.92% |
| 30 Jun, 20 | 100.14% | 1.40% |
| 31 Mar, 20 | 84.45% | 1.61% |
| 31 Dec, 19 | 72.50% | 1.83% |
| 30 Sep, 19 | 62.93% | 1.03% |
| 30 Jun, 19 | 78.36% | 1.45% |
| 31 Mar, 19 | 73.61% | 0.39% |
| 31 Dec, 18 | 138.26% | 0.78% |
| 30 Sep, 18 | 133.13% | - |
As of 30 Jun 24, Crinetics Pharmaceuticals is held by 14.79% institutional shareholders, representing a 0.12% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 58 | -54.33% |
| 31 Mar, 24 | 127 | 13.39% |
| 31 Dec, 23 | 112 | -16.42% |
| 30 Sep, 23 | 134 | 63.41% |
| 30 Jun, 23 | 82 | 6.49% |
| 31 Mar, 23 | 77 | 30.51% |
| 31 Dec, 22 | 59 | -7.81% |
| 30 Sep, 22 | 64 | 3.23% |
| 30 Jun, 22 | 62 | 10.71% |
| 31 Mar, 22 | 56 | -37.78% |
| 31 Dec, 21 | 90 | 80.00% |
| 30 Sep, 21 | 50 | -15.25% |
| 30 Jun, 21 | 59 | 84.38% |
| 31 Mar, 21 | 32 | -38.46% |
| 31 Dec, 20 | 52 | 100.00% |
| 30 Sep, 20 | 26 | -61.76% |
| 30 Jun, 20 | 68 | 223.81% |
| 31 Mar, 20 | 21 | -36.36% |
| 31 Dec, 19 | 33 | 26.92% |
| 30 Sep, 19 | 26 | -36.59% |
| 30 Jun, 19 | 41 | - |
| 31 Mar, 19 | 41 | 51.85% |
| 31 Dec, 18 | 27 | -44.90% |
| 30 Sep, 18 | 49 | - |
58 institutional shareholders have increased their position in CRNX stock as of 30 Jun 24 compared to 127 in the previous quarter (a -54.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 23 | -58.93% |
| 31 Mar, 24 | 56 | - |
| 31 Dec, 23 | 56 | 86.67% |
| 30 Sep, 23 | 30 | -9.09% |
| 30 Jun, 23 | 33 | 13.79% |
| 31 Mar, 23 | 29 | -17.14% |
| 31 Dec, 22 | 35 | 25.00% |
| 30 Sep, 22 | 28 | -6.67% |
| 30 Jun, 22 | 30 | -25.00% |
| 31 Mar, 22 | 40 | 110.53% |
| 31 Dec, 21 | 19 | -5.00% |
| 30 Sep, 21 | 20 | 53.85% |
| 30 Jun, 21 | 13 | -48.00% |
| 31 Mar, 21 | 25 | 66.67% |
| 31 Dec, 20 | 15 | -37.50% |
| 30 Sep, 20 | 24 | 200.00% |
| 30 Jun, 20 | 8 | -61.90% |
| 31 Mar, 20 | 21 | 90.91% |
| 31 Dec, 19 | 11 | -35.29% |
| 30 Sep, 19 | 17 | 112.50% |
| 30 Jun, 19 | 8 | -11.11% |
| 31 Mar, 19 | 9 | -18.18% |
| 31 Dec, 18 | 11 | - |
| 30 Sep, 18 | - | - |
23 institutional shareholders have reduced their position in CRNX stock as of 30 Jun 24 compared to 56 in the previous quarter (a -58.93% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 95 | -56.82% | 10,694,544 | -86.70% | 14.79% | 0.12% | 58 | -54.33% | 23 | -58.93% |
| 31 Mar, 24 | 220 | 11.68% | 80,408,468 | 13.80% | 111.23% | 0.75% | 127 | 13.39% | 56 | - |
| 31 Dec, 23 | 197 | - | 70,656,199 | 3.13% | 121.67% | 0.84% | 112 | -16.42% | 56 | 86.67% |
| 30 Sep, 23 | 197 | 40.71% | 68,511,935 | 27.20% | 120.60% | 1.22% | 134 | 63.41% | 30 | -9.09% |
| 30 Jun, 23 | 140 | 9.38% | 53,863,454 | -2.11% | 99.24% | 0.95% | 82 | 6.49% | 33 | 13.79% |
| 31 Mar, 23 | 128 | 4.07% | 55,022,766 | 0.25% | 102.07% | 0.92% | 77 | 30.51% | 29 | -17.14% |
| 31 Dec, 22 | 123 | 4.24% | 54,887,252 | 6.77% | 105.59% | 1.16% | 59 | -7.81% | 35 | 25.00% |
| 30 Sep, 22 | 118 | 5.36% | 51,405,886 | 1.47% | 95.61% | 1.03% | 64 | 3.23% | 28 | -6.67% |
| 30 Jun, 22 | 112 | -3.45% | 50,661,253 | 11.21% | 96.46% | 1.05% | 62 | 10.71% | 30 | -25.00% |
| 31 Mar, 22 | 116 | -1.69% | 45,553,050 | 2.89% | 96.03% | 1.00% | 56 | -37.78% | 40 | 110.53% |
| 31 Dec, 21 | 118 | 28.26% | 44,275,109 | 31.64% | 97.89% | 1.27% | 90 | 80.00% | 19 | -5.00% |
| 30 Sep, 21 | 92 | 12.20% | 33,632,719 | 2.33% | 87.79% | 1.12% | 50 | -15.25% | 20 | 53.85% |
| 30 Jun, 21 | 82 | 5.13% | 32,867,947 | 6.96% | 88.69% | 1.02% | 59 | 84.38% | 13 | -48.00% |
| 31 Mar, 21 | 78 | -8.24% | 30,730,606 | 1.00% | 93.09% | 0.93% | 32 | -38.46% | 25 | 66.67% |
| 31 Dec, 20 | 85 | 21.43% | 30,426,262 | 0.30% | 99.93% | 1.17% | 52 | 100.00% | 15 | -37.50% |
| 30 Sep, 20 | 70 | -11.39% | 30,335,349 | -3.55% | 92.23% | 0.92% | 26 | -61.76% | 24 | 200.00% |
| 30 Jun, 20 | 79 | 41.07% | 31,451,446 | 52.09% | 100.14% | 1.40% | 68 | 223.81% | 8 | -61.90% |
| 31 Mar, 20 | 56 | -3.45% | 20,679,658 | 17.99% | 84.45% | 1.61% | 21 | -36.36% | 21 | 90.91% |
| 31 Dec, 19 | 58 | -4.92% | 17,526,233 | 15.04% | 72.50% | 1.83% | 33 | 26.92% | 11 | -35.29% |
| 30 Sep, 19 | 61 | -3.17% | 15,234,861 | -19.53% | 62.93% | 1.03% | 26 | -36.59% | 17 | 112.50% |
| 30 Jun, 19 | 63 | 1.61% | 18,931,383 | 6.73% | 78.36% | 1.45% | 41 | - | 8 | -11.11% |
| 31 Mar, 19 | 62 | 24.00% | 17,737,450 | 5.66% | 73.61% | 0.39% | 41 | 51.85% | 9 | -18.18% |
| 31 Dec, 18 | 50 | 2.04% | 16,786,976 | 3.85% | 138.26% | 0.78% | 27 | -44.90% | 11 | - |
| 30 Sep, 18 | 49 | - | 16,164,910 | - | 133.13% | - | 49 | - | - | - |
Crinetics Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Crinetics Pharmaceuticals's stock was made by Betz Stephen F. on Aug 14 2024, selling 3,000 shares at $47.68 per share (valued at $143.04K).
Crinetics Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 7 | 15 | 46.67% |
| Q2 2024 | 21 | 19 | 110.53% |
| Q1 2024 | 28 | 26 | 107.69% |
| Q4 2023 | 6 | 14 | 42.86% |
| Q3 2023 | 1 | 4 | 25.00% |
| Q2 2023 | 16 | 6 | 266.67% |
| Q1 2023 | 14 | 9 | 155.56% |
| Q4 2022 | 3 | 7 | 42.86% |
| Q3 2022 | 3 | 7 | 42.86% |
| Q2 2022 | 14 | 5 | 280.00% |
| Q1 2022 | 20 | 10 | 200.00% |
| Q4 2021 | 3 | 20 | 15.00% |
| Q3 2021 | 5 | 9 | 55.56% |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 2 | - | - |
| Q3 2020 | 1 | 2 | 50.00% |
| Q2 2020 | 7 | 11 | 63.64% |
| Q1 2020 | 3 | 26 | 11.54% |
| Q4 2019 | 1 | 2 | 50.00% |
7 total buy trades, and 15 total sell trades (buy/sell ratio of 0.47%) were made by Crinetics Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | - | 11 | - |
| Q1 2024 | - | 14 | - |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 1 | 4 | 25.00% |
| Q1 2023 | - | 4 | - |
| Q4 2022 | - | 6 | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | 2 | 5 | 40.00% |
| Q1 2022 | - | 10 | - |
| Q4 2021 | 1 | 11 | 9.09% |
| Q3 2021 | - | 5 | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 2 | - | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | 1 | 10 | 10.00% |
| Q1 2020 | - | 21 | - |
| Q4 2019 | - | 1 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Crinetics Pharmaceuticals's stocks.
Crinetics Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| VRDN | Viridian Therapeutics, Inc. |
| MRUS | Merus N.V. |
| ALEC | Alector, Inc. |
| RGNX | REGENXBIO Inc. |
| INBX | Inhibrx, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| LIAN | LianBio |
| LYEL | Lyell Immunopharma, Inc. |
| KRON | Kronos Bio, Inc. |
| PASG | Passage Bio, Inc. |
| GPCR | Structure Therapeutics Inc. |
| KZR | Kezar Life Sciences, Inc. |
| CYTK | Cytokinetics, Incorporated |
CRNX Ownership FAQ
Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals is owned by institutional shareholders (14.79%), insiders (2.08%), and public (83.12%). The largest institutional shareholder of Crinetics Pharmaceuticals is BLACKROCK INC. (8.62% of total shares) and the top mutual fund owner is Tema ETF Trust (0.88% of total shares).
Who are the major institutional shareholders of Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals's major institutional shareholders are BLACKROCK INC., DRIEHAUS CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 35.81% of the company's share outstanding.
How many Crinetics Pharmaceuticals shareholders are there?
As of Jun 2024, there are 95 institutional shareholders of Crinetics Pharmaceuticals.
What percentage of Crinetics Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 6.23M shares of Crinetics Pharmaceuticals, representing 8.62% of the company's total shares outstanding, valued at $279.06M (as of Jun 2024).
What percentage of Crinetics Pharmaceuticals is owned by DRIEHAUS CAPITAL MANAGEMENT LLC?
As of Jun 2024, DRIEHAUS CAPITAL MANAGEMENT LLC holds 6.11M shares of Crinetics Pharmaceuticals (CRNX), compromising 8.46% of the company, valued at $273.76M.
What percentage of Crinetics Pharmaceuticals is owned by WELLINGTON MANAGEMENT GROUP LLP?
WELLINGTON MANAGEMENT GROUP LLP is the third largest holder of Crinetics Pharmaceuticals. The company owns 4.62M of the company's shares outstanding (worth $206.95M).